封面
市場調查報告書
商品編碼
1678779

全球心電圖貼片與動態心電圖監測儀市場 - 2025 年至 2033 年

Global ECG Patches and Holter Monitor Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球心電圖貼片和動態心電圖監測市場規模達到 18.6454 億美元,預計到 2033 年將達到 59.5062 億美元,在 2025-2033 年預測期內的複合年成長率為 13.7%。

ECG 貼片和 Holter 監測儀是穿戴式醫療設備,用於持續心臟監測以檢測心律不整。 ECG 貼片可以記錄 24 至 72 小時內的心臟活動,而 Holter 監視器則是專為長期監護而設計的攜帶式、電池供電設備。這些設備可幫助醫療保健提供者分析心臟功能、診斷心血管狀況並實現遠端患者監控,從而改善心臟病的早期發現和管理。

市場動態:

促進因素與約束因素

穿戴式和遠端監控設備的採用日益增多

全球心電圖貼片和動態心電圖監測市場受到穿戴式和遠端監測設備的興起的推動,特別是由於心血管疾病的盛行率不斷上升和數位健康技術的進步。穿戴式心電圖貼片提供即時資料傳輸,使醫療保健提供者能夠遠端檢測心臟異常。人工智慧和基於雲端的分析的整合進一步增強了早期診斷和患者結果。市場擴張的動力來自於人們對家庭醫療保健的偏好,尤其是老年人和慢性病患者。

例如,2024 年 3 月,從三星分拆出來的數位醫療公司 Wellys 與 Artella Solutions 合作在美國推出了一項遠距心臟監測服務。此次合作以 Welly 經 FDA 批准的 S-Patch 心電圖監測解決方案為基礎,目前採用經 FDA 批准的 S-Patch ExL 設備。 ExL 車型允許使用單一連結電池進行約 14 天的延長測試期,並於 2 月初獲得了 FDA 批准。此次擴展使 Welly 能夠擴大其在擴展 Holter 服務和移動心臟遙測服務中的覆蓋範圍。

高成本和報銷挑戰

預計心電圖貼片和動態心電圖監測儀的高成本也將在預測期內阻礙市場發展。這些產品的高成本可能會對醫療保健系統、醫院和診斷診所造成沉重的財務負擔。預算限制可能會限制心電圖貼片和動態心電圖監測儀的廣泛應用,尤其是在資源有限的環境中。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動態

  • 影響因素
    • 驅動程式
      • 穿戴式和遠端監控設備的採用日益增多
    • 限制
      • 高成本和報銷挑戰
    • 機會
    • 影響分析

第5章:戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析:最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章:按裝置類型

  • 心電圖貼片
  • 動態心電圖監測

第 7 章:按應用

  • 監控
  • 診斷

第 8 章:按最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心
  • 診斷中心
  • 其他

第9章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

  • Koninkluke Philips NV
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Bittium
  • Meditech Equipment Co., Ltd
  • ACS Diagnostics
  • Viatom Application Co., Ltd.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Spacelabs Healthcare, Inc.
  • SmartCardia Inc.
  • dms-service LLC
  • Similar data will be provided for each market player.
  • ReelCardio 有限責任公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 巴迪診斷
  • 活體組織
  • 心臟洞察
  • 將為每個市場參與者提供類似的資料。

第 12 章:附錄

簡介目錄
Product Code: MD7215

The Global ECG Patches and Holter Monitor Market reached US$ 1,864.54 million in 2024 and is expected to reach US$ 5,950.62 million by 2033, growing at a CAGR of 13.7% during the forecast period of 2025-2033.

ECG patches and Holter monitors are wearable medical devices used for continuous cardiac monitoring to detect irregular heart rhythms. ECG patches record heart activity over 24 to 72 hours, while Holter monitors are portable, battery-operated devices designed for long-term monitoring. These devices aid healthcare providers in analyzing heart function, diagnosing cardiovascular conditions, and enabling remote patient monitoring, improving early detection and management of heart diseases.

Market Dynamics: Drivers & Restraints

Increasing Adoption of Wearable and Remote Monitoring Devices

The global ECG patches and Holter monitor market is driven by the rise in wearable and remote monitoring devices, particularly due to the increasing prevalence of cardiovascular diseases and digital health technology advancements. Wearable ECG patches provide real-time data transmission, enabling healthcare providers to detect cardiac abnormalities remotely. The integration of AI and cloud-based analytics further enhances early diagnosis and patient outcomes. The market's expansion is driven by the preference for home-based healthcare, especially among the elderly and those with chronic conditions.

For instance, in March 2024, Wellysis, a digital healthcare company spun off from Samsung, launched a remote cardiac monitoring service in the US in partnership with Artella Solutions. The partnership builds on Wellysis' FDA-cleared S-Patch electrocardiogram monitoring solution, now featuring the FDA-cleared S-Patch ExL device. The ExL model allows for extended testing periods of about 14 days on a single coin battery and received FDA clearance in early February. This expansion enables Wellysis to expand its reach in the Extended Holter service and Mobile Cardiac Telemetry service.

High Cost and Reimbursement Challenges

The high costs associated with the ECG patches and Holter monitors is also expected to hamper the market over the forecast period. High costs associated with these products may impose a significant financial burden on healthcare systems, hospitals and diagnostic clinics. Budget constraints could limit the widespread adoption of ECG patches and Holter monitors, especially in resource-limited settings.

Segment Analysis

The global ECG patches and holter monitor market is segmented based on device type, application, end user and region.

Device Type:

ECG Patches in the device type segment are expected to dominate with the highest market share

ECG patches are a user-friendly, wireless, and comfortable alternative to traditional Holter monitors in cardiac monitoring. They provide continuous heart rhythm tracking, enabling early detection of arrhythmias and other cardiovascular conditions. The increasing adoption of ECG patches is driven by AI-powered analytics, cloud-based data sharing, and improved battery life. Their integration into home healthcare and ambulatory care settings reduces hospital visits and improves patient compliance.

ECG patches store data that can be later analyzed by healthcare professionals. This data provides a comprehensive overview of the patient's heart activity, aiding in accurate diagnosis and personalized treatment plans. ECG patches are increasingly being used as an alternative to traditional Holter monitors, offering a more discreet and comfortable option for prolonged heart monitoring. Patients can continue their daily activities without disruption while wearing these patches.

Geographical Analysis

North America is expected to hold a significant position in the ECG Patches and Holter Monitor market share.

North America is a major player in the global ECG patches and Holter monitor market due to the increasing prevalence of cardiovascular diseases, the geriatric population, and increased healthcare expenditure. The region's advanced healthcare infrastructure, favourable reimbursement policies, and technological advancements in wearable cardiac monitoring devices drive market growth. The presence of major market players and their innovative product launches and increased awareness about remote patient monitoring and early disease detection further enhance adoption rates.

Europe is growing at the fastest pace in the ECG Patches and Holter Monitor market.

Europe is driving the growth of the ECG patches and Holter monitor market due to healthcare digitization, government initiatives, and preventive healthcare. The aging population and improved healthcare access support the market's expansion. The adoption of wearable and AI-driven technologies, along with a well-established regulatory framework, further strengthens market penetration. Key medical technology companies and ongoing research into innovative diagnostic solutions further strengthen Europe's role in driving market growth.

For instance, in May 2024, Royal Philips successfully launched its ambulatory cardiac monitoring service in Spain using a wearable ePatch and the Cardiologs analytics platform. The service uses Holter monitors to detect life-threatening heart arrhythmias, improve patient comfort, and potentially improve clinical outcomes.

Competitive Landscape

The major global players in the ECG Patches and Holter Monitor market include Koninkluke Philips N.V, Bittium, Meditech Equipment Co., Ltd, ACS Diagnostics, Viatom Technology Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., Spacelabs Healthcare, Inc, SmartCardia Inc, and dms-service LLC, among others.

Key Developments

  • In May 2024, Vivalink, a leading provider of digital healthcare solutions, launched a technology solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care. This integration aims to reduce the cost of ambulatory cardiac monitoring services by streamlining delivery and enhancing patient care.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ECG Patches and Holter Monitor market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Device Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Wearable and Remote Monitoring Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Reimbursement Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Device Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 6.1.2. Market Attractiveness Index, By Device Type
  • 6.2. ECG Patches*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Holter Monitors

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Monitoring*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diagnostics

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Diagnostic Centers
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Koninkluke Philips N.V.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Bittium
  • 11.3. Meditech Equipment Co., Ltd
  • 11.4. ACS Diagnostics
  • 11.5. Viatom Application Co., Ltd.
  • 11.6. GE HealthCare Technologies Inc.
  • 11.7. Hill-Rom Holdings, Inc.
  • 11.8. Spacelabs Healthcare, Inc.
  • 11.9. SmartCardia Inc.
  • 11.10. dms-service LLC
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. ReelCardio LLC*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Bardy Diagnostics
  • 11.13. AliveCor
  • 11.14. Cardiac Insight
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us